Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)

China · Delayed Price · Currency is CNY

22.74

+1.11 (5.13%)

At close: Aug 4, 2026

SHA:688217 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	162.81	177.26	242.31	258.21	424.3	290.95
Revenue Growth	-28.73%	-26.84%	-6.16%	-39.14%	45.83%	2.11%
Gross Profit	118.55	129.31	179.47	187.65	257.7	212.12
Operating Income	-48.67	-38.8	-19.15	-10.08	72.81	27.04
Net Income	-58.72	-50.38	-15.76	7.93	40.47	47.33
Earnings Per Share	-1.06	-0.91	-0.28	0.14	0.73	0.95
EPS Growth	-	-	-	-80.82%	-23.16%	2.15%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	225.8	225.29	232.72	234.31	294.83	324.88
Total Debt	2.44	2.78	22.42	29.33	13.92	9.53
Net Cash (Debt)	223.36	222.51	210.3	204.98	280.91	315.35
Net Cash Growth	1.88%	5.80%	2.60%	-27.03%	-10.92%	121.80%
Net Cash Per Share	4.04	4.02	3.74	3.62	5.07	6.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	36.73	45.55	59.98	45.1	73.07	77.97
Capital Expenditures	-25.46	-26.76	-39.41	-109.09	-106.57	-95.6
Free Cash Flow	11.27	18.79	20.57	-64	-33.5	-17.63
Free Cash Flow Growth	-47.31%	-8.67%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	72.82%	72.95%	74.07%	72.67%	60.73%	72.91%
Operating Margin	-29.89%	-21.89%	-7.90%	-3.91%	17.16%	9.29%
Pretax Margin	-37.18%	-28.62%	-11.75%	-3.64%	16.85%	14.59%
Profit Margin	-36.06%	-28.42%	-6.51%	3.07%	9.54%	16.27%
FCF Margin	6.92%	10.60%	8.49%	-24.79%	-7.90%	-6.06%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.340	-	-	0.180
Dividend Per Share Growth	0%	-	-	-
Dividend Yield	1.57%	-	-	0.51%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	252.00	48.54	85.39
Forward PE	-	105.40	76.83	41.61	37.81	-
P/FCF Ratio	105.90	77.41	49.48	-	-	-
PS Ratio	7.33	8.20	4.20	7.74	4.63	13.89